Galectin-9
Galectin-9 is firstly isolated from mouse embryonic kidney as a 36 kDa beta-galactoside lectin protein. The protein has N- and C- terminal carbohydrate-binding domains connected by a link peptide. Multiple alternatively spliced transcript variants have been found. Galectin-9 is one of the most studied ligand for HAVCR2 (TIM-3) and is expressed on various tumor cells. However, it can also interact with other proteins (CLEC7A, CD137, CD40). The expression of galectin-9 has been detected on various hematological malignancies, such as CLL, MDS, Hodgkin and Non-Hodgkin lymphomas, AML or solid tumors, such as lung cancer, breast cancer, and hepatocellular carcinoma.| CAT | Product Name | Source | Product Overview | Target | Type | Datasheet | Size | Price |
|---|---|---|---|---|---|---|---|---|
| VAng-Cr3857 | Recombinant Galectin-9 Protein (Met1-Gln148) [His] | Mammalian cells | Recombinant Galectin-9 Protein (Met1-Gln148) fused with a His tag at N-terminus was expressed in Mammalian cells, with a molecular weight of 16.39 kDa. (Uniprot ID: O00182) | Galectin-9 | Tumor Antigens |  |
100 µg | Inquiry |
| VAng-1671Lsx | Human Galectin-9 Protein (Ala 2-Thr 323) [His] | HEK293 Cells. | Human Galectin-9, His tag, is expressed in human 293 cells. (Uniprot ID: BAA31542) | Galectin-9 | Tumor Antigens | |
50 µg | Inquiry |
| VAng-1672Lsx | Human Galectin-9 Protein (Met 1-Thr 323) | E. coli. | Human Galectin-9 is expressed in E. coli. (Uniprot ID: O00182-2) | Galectin-9 | Tumor Antigens | |
100 µg | Inquiry |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
